Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study

Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts

(2017) H Grundmann et al.   Eurosurveillance

Predictive Models for Identification of Hospitalized Patients Harboring KPC-Producing Klebsiella pneumoniae

(2014) Mario Tumbarello et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems

(2014) George L. Daikos et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treating infections caused by carbapenemase-producing Enterobacteriaceae

(2014) L.S. Tzouvelekis et al.   CLINICAL MICROBIOLOGY AND INFECTION

Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study

(2014) M. Giannella et al.   CLINICAL MICROBIOLOGY AND INFECTION

Risk Factors for Treatment Failure of Polymyxin B Monotherapy for Carbapenem-Resistant Klebsiella pneumoniae Infections

(2013) Yanina Dubrovskaya et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence

(2013) Matthew E. Falagas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Predictors of mortality in multidrug-resistantKlebsiella pneumoniaebloodstream infections

(2013) Pierluigi Viale et al.   Expert Review of Anti-Infective Therapy

Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012

(2013) R. P. Dellinger et al.   INTENSIVE CARE MEDICINE

Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

(2013) L Silvia Munoz-Price et al.   LANCET INFECTIOUS DISEASES

Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens

(2012) Zubair A. Qureshi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carbapenem-Sparing Antibiotic Regimens for Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit

(2012) F. Sbrana et al.   CLINICAL INFECTIOUS DISEASES

Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy

(2012) M. Tumbarello et al.   CLINICAL INFECTIOUS DISEASES

Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria

(2012) M. Akova et al.   CLINICAL MICROBIOLOGY AND INFECTION

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

(2012) R. Cantón et al.   CLINICAL MICROBIOLOGY AND INFECTION

High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality

(2012) A. Capone et al.   CLINICAL MICROBIOLOGY AND INFECTION

Assessment of Antimicrobial Combinations for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae

(2012) Elizabeth B. Hirsch et al.   JOURNAL OF INFECTIOUS DISEASES

Treatment of Klebsiella Pneumoniae Carbapenemase (KPC) infections: a review of published case series and case reports

(2012) Grace C Lee et al.   Annals of Clinical Microbiology and Antimicrobials

In VitroPharmacodynamics of Simulated Pulmonary Exposures of Tigecycline Alone and in Combination againstKlebsiella pneumoniaeIsolates Producing a KPC Carbapenemase

(2011) Dora E. Wiskirchen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention

(2011) N. Gupta et al.   CLINICAL INFECTIOUS DISEASES

Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment

(2011) O. Zarkotou et al.   CLINICAL MICROBIOLOGY AND INFECTION

Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?

(2011) G.L. Daikos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time–kill assay

(2011) Spyros Pournaras et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection

(2010) Elizabeth B. Hirsch et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae

(2010) A. Elemam et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Risk Factors and Prognosis of Nosocomial Bloodstream Infections Caused by Extended-Spectrum- -Lactamase-Producing Escherichia coli

(2010) J. Rodriguez-Bano et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA

(2009) Andrea Endimiani et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies

(2008) Gopi Patel et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY